Matches in Nanopublications for { ?s ?p "[Due to the heterogeneity of prostate cancer, the combination of several biomarkers is necessary to accurately assess the presence of prostate cancer, predict its potential clinical outcome and decide on appropriate therapy (e.g.PARP inhibitors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_assertion description "[Due to the heterogeneity of prostate cancer, the combination of several biomarkers is necessary to accurately assess the presence of prostate cancer, predict its potential clinical outcome and decide on appropriate therapy (e.g.PARP inhibitors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245923.RAd6GIgRqZdjOFXoz60R-MmApYUjeiw-yEUFzFJoJ34j8130_provenance.
- NP1245929.RAGwEfIIIFHFtRAWBWvo3ERV7XRmbtdV9EEllYy_wNTbU130_assertion description "[Due to the heterogeneity of prostate cancer, the combination of several biomarkers is necessary to accurately assess the presence of prostate cancer, predict its potential clinical outcome and decide on appropriate therapy (e.g.PARP inhibitors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245929.RAGwEfIIIFHFtRAWBWvo3ERV7XRmbtdV9EEllYy_wNTbU130_provenance.
- NP1245925.RA4F2eVwfNYoBga_FaTfVah-ObVRCDXuMHGimF-GYK8oI130_assertion description "[Due to the heterogeneity of prostate cancer, the combination of several biomarkers is necessary to accurately assess the presence of prostate cancer, predict its potential clinical outcome and decide on appropriate therapy (e.g.PARP inhibitors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245925.RA4F2eVwfNYoBga_FaTfVah-ObVRCDXuMHGimF-GYK8oI130_provenance.
- NP1245927.RA83d0mF8myN7qpd7_jjBGgVp96BxnHhMHRQeBdYOGgFo130_assertion description "[Due to the heterogeneity of prostate cancer, the combination of several biomarkers is necessary to accurately assess the presence of prostate cancer, predict its potential clinical outcome and decide on appropriate therapy (e.g.PARP inhibitors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245927.RA83d0mF8myN7qpd7_jjBGgVp96BxnHhMHRQeBdYOGgFo130_provenance.